What is the global market size of T-cell Therapy Market?

Global T-cell Therapy Market size was valued at USD 7095.83 million in 2021 and is poised to grow from USD 8344.7 million in 2022 to USD 35898.15 million by 2030, growing at a CAGR of 17.6% in the forecast period (2023-2030).

What is the key driver of Global T-cell Therapy Market?

Following the FDA's approval of Yescarta, Kymriah, and Tecartus, a number of businesses have switched from developing protein- and small-molecule-based therapeutics to adoptive therapies as their primary business model. The market for T-cell treatment has grown as a result of strategic expenditures made in this area by both public and commercial organisations.

What is the key market trend for Global T-cell Therapy Market?

CAR T-cell therapies are being used in treatment of solid tumors. CAR T-cell treatment has demonstrated a considerable potential benefit in diffusing midline glioma, a deadly paediatric tumour that affects school-age children and young adults. A study using CAR T cells in animal models to promote prolonged eradication of diffuse midline glioma tumours produced encouraging findings, although some of the animals perished due to toxicity-related problems. For the therapy of brain tumours, intracerebroventricular (ICV) distribution of CAR T was much more effective and less toxic than systemic delivery was found later.

Which region accounted for the largest share in Global T-cell Therapy Market?

North America held the largest market share of Global T cell therapy Market in 2021 and accounted for the largest revenue share of around 41% in 2021. Strong research, a thriving industry, and a significant number of clinical trials for T-cell treatments being carried out in the U.S. have all significantly aided in the region's market supremacy. Additionally, the market has grown significantly as a result of the rising number of regulatory approvals in the U.S. and Canada as well as the region's shifting reimbursement environment. Additionally, the expansion of the regional market is aided by the large number of medical facilities that provide CAR-T cell therapy.

Top T-cell Therapy Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the T-cell Therapy Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading T-cell Therapy industry players.

T-cell Therapy Market Competitive Landscape

Global T cell therapy Market is fragmented and competitive due to the presence of major players. Companies are clamouring to invest in the creation of innovative CAR T-cell treatment due to the exponential increase in the use of precision medicine on a worldwide scale. To maintain a competitive edge and increase their market position in the worldwide Tcell therapy market, leading companies are increasingly focusing on implementing tactics such as adopting new technology, product developments, mergers and acquisitions, joint venture, alliances, and partnerships. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D.

T-cell Therapy Market Top Player's Company Profiles

Novartis AG
Merck KGaA
Gilead Sciences Inc.
Kite Pharma, Inc.
Juno Therapeutics Inc.
Pfizer Inc.
Celgene Corporation
bluebird bio, Inc.
Adaptimmune Therapeutics plc
Atara Biotherapeutics, Inc.
Mustang Bio, Inc.
TCR² Therapeutics Inc.
Autolus Therapeutics plc
Immunocore Limited
Eureka Therapeutics, Inc.
Ziopharm Oncology, Inc.
Precision Biosciences Inc.
Sorrento Therapeutics, Inc.
Fate Therapeutics, Inc.
Celyad Oncology SA
Caribou Biosciences, Inc.

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?

REQUEST FREE CUSTOMIZATION

FAQs

Global T-cell Therapy Market size was valued at USD 9813.37 Million in 2024 and is poised to grow from USD 11540.52 Million in 2025 to USD 42216.68 Million by 2033, growing at a CAGR of 17.6% during the forecast period (2026–2033).

Key vendors in the T-cell Therapy Market include Novartis AG, Gilead Sciences, Inc., Bristol Myers Squibb, Johnson & Johnson, Autolus Therapeutics plc, Cellectis S.A., Legend Biotech Corporation, Adaptimmune Therapeutics plc, Precision BioSciences, Inc., and Caribou Biosciences, Inc.. These companies are advancing CAR-T, TCR-T, and other engineered T-cell therapies for oncology and autoimmune diseases, focusing on next-generation cell engineering, gene editing, and expanding clinical pipelines.

The key driver of the T-cell Therapy Market is the increasing prevalence of cancer and the growing demand for highly targeted immunotherapies. Advancements in CAR-T and TCR-T technologies, rising investments in cell and gene therapy research, expanding clinical trials, and increasing regulatory approvals for innovative T-cell therapies are driving market growth.

The key market trend in the T-cell Therapy Market is the rapid advancement of next-generation engineered T-cell therapies, including allogeneic (off-the-shelf), gene-edited, and armored CAR-T cell platforms. Companies are leveraging CRISPR gene editing, AI-driven target discovery, and advanced cell engineering to improve treatment efficacy, reduce manufacturing time, expand applications beyond hematologic cancers into solid tumors, and lower production costs.

North America accounted for the largest share in the T-cell Therapy Market due to its strong biotechnology ecosystem, high investment in cell and gene therapy research, robust clinical trial activity, and the presence of leading biopharmaceutical companies. Favorable regulatory support, increasing approvals of CAR-T therapies, and advanced healthcare infrastructure further strengthen the region's market leadership.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Luca Giovannini, Marketing Innovation Senior Manager, Trelleborg.

Top T-cell Therapy Companies

T-cell Therapy Market Competitive Landscape

FAQs

What is the global market size of T-cell Therapy Market?

Who are the key vendors in the T-cell Therapy Market?

What is the key driver of T-cell Therapy Market?

What is the key market trend for T-cell Therapy Market?

Which region accounted for the largest share in T-cell Therapy Market?

Request Free Customization